Coastland Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Coastland Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-443,619	Closed	-$9.28M	–	154
2016 Q3	$9.28M	Buy	+443,619	New	+$5.11M	0.36%	59

Coastland Capital's VTAE Position: Q4 2016 in Review

Coastland Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 443,619 shares — an estimated $9.28M sold.

Coastland Capital first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $9.28M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Coastland Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Coastland Capital sold 443,619 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $9.28M.
Coastland Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Coastland Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $9.28M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Coastland Capital's 13F filing for Q4 2016, filed 14 Feb 2017.